CD4 and neoplasm: Using experimental in vitro models, we and others demonstrated that tumor cells can trigger in human CD4+ and CD8+ T lymphocytes the acquisition of suppressive functions and phenotypic alterations that resembled those found in senescent cells (13, 14).